本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国血液技术

50.01
+0.02000.04%
盘后50.010.00000.00%17:32 EDT
成交量:46.28万
成交额:2,315.72万
市值:24.09亿
市盈率:15.26
高:50.34
开:49.58
低:49.00
收:49.99
52周最高:94.99
52周最低:47.32
股本:4,817.73万
流通股本:4,759.82万
量比:1.04
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):3.28
每股收益(LYR):3.33
净资产收益率:18.27%
总资产收益率:6.52%
市净率:2.73
市盈率(LYR):15.01

数据加载中...

2020/05/20

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/17

重要事件披露

8-K - Current report
2020/04/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, items 2.02 and 9.01
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, items 1.02, 7.01, and 9.01
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/01

重要事件披露

Current report, items 2.02 and 9.01
2019/10/29

持股变动声明

Statement of changes in beneficial ownership of securities
2019/10/29

持股变动声明

Statement of changes in beneficial ownership of securities